Author:
Dhande S. R,Bhutkar S. P.,Mahadik J. V.,
Abstract
Co-administration of prescribed drug with that of over the counter products may either lead to altered therapeutic effect, adverse effects or depleted efficacy of one or both drugs. One such example is geriatric patients being treated with ayurvedic cardioprotectives formulations for ischemia generally suffer from bowel movement discomfort and tend to consume herbal laxatives simultaneously without physician’s consent. The proposed study was undertaken to determine whether any interaction exists when Arjuna, a cardioprotective agent is concomitantly administered orally with Haritaki churna, a laxative agent, in isoproterenol (subcutaneous administration) induced ischemic rats on pharmacodynamic level. Data was statistically evaluated by comparing the effect of combination group with that of isoproterenol control and Arjuna group on electrocardiogram (ECG) patterns, blood serum parameters, gastric motility using ONE WAY ANNOVA, p < 0.05 followed by Tukey’s multiple comparison test. Results suggests that there is significant decrease in cardioprotective efficacy of Arjuna when administered together with Haritaki.
Publisher
Indian Drug Manufacturers' Association (IDMA)
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Reference32 articles.
1. 1) Patwardhan B., Vaidya A. and Chorghade M.: Ayurveda and natural products drug discovery, Current Science, 2004, 86(6), 789-799.
2. 2) Pandey M., Rastogi S. and Rawat A.: Indian Traditional Ayurvedic System of Medicine and Nutritional Supplementation, Evidence-Based Complementary and Alternative Medicine, 2013, 2013, 1-12.
3. 3) Dhande S., Lokegaonkar D. and Gursahani M.: Health Practitioners’ view on concomitant use of OTC and prescription drugs: A Survey Report, International Journal of Universal Pharmacy and Bio Sciences, 2015, 4(3), 38-51.
4. 4) Valli G. and Giardina E.: Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects, Journal of the American College of Cardiology, 2002, 39(7), 1083-1095.
5. 5) Singh N.: Concept of Drug Interaction, International Research Journal of Pharmacy, 2012, 3(7), 120-122.